.svg){kind=small}
Mar-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Head & Heal has shown a promising upward trajectory in the New York concentrates market. Starting from a rank of 33 in December 2025, the brand has climbed steadily, reaching the 20th position by March 2026. This consistent improvement suggests a growing consumer base and increased market penetration in the concentrates category. Notably, their sales figures have seen a significant rise, particularly between January and February 2026, indicating successful strategies in product placement or consumer engagement. However, the brand did not make it into the top 30 in December, which highlights a previous gap in market presence that has since been effectively addressed.
In the tincture and sublingual category, Head & Heal has maintained a strong position, consistently holding the second rank from December 2025 through March 2026 in New York. This stability indicates a robust product offering that resonates well with consumers in this segment. Despite a noticeable dip in sales from December to January, the brand rebounded in March, suggesting a potential seasonal fluctuation or strategic adjustment that successfully recaptured consumer interest. The ability to sustain such a high rank over multiple months is a testament to the brand's stronghold in this category, although maintaining this position in the coming months will be crucial for continued success.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in New York, Head & Heal consistently holds the second rank from December 2025 through March 2026. Despite maintaining this position, the brand faces stiff competition from Ayrloom, which dominates the market as the top-ranked brand throughout the same period. Head & Heal's sales figures, though lower than Ayrloom's, show a notable resilience, particularly against Mfny (Marijuana Farms New York) and Veterans Choice Creations (VCC), which consistently rank third and fourth, respectively. The sales trend for Head & Heal indicates a slight decline from December to February, followed by a recovery in March, suggesting potential seasonal influences or successful promotional efforts. This stable ranking amidst fluctuating sales highlights Head & Heal's strong brand presence and customer loyalty in a highly competitive market.
Notable Products
In March 2026, Head & Heal's top-performing product was the Max Strength THC Tincture (1000mg THC, 30ml) in the Tincture & Sublingual category, maintaining its first-place rank for the fourth consecutive month with sales of 1449 units. The CBD/THC/CBN 2:1:2 Sleep Tincture (600mg CBD, 300mg THC, 600mg CBN, 30ml) also held steady in second place, reflecting consistent consumer demand. The Hybrid RSO Dablicator (1g) climbed to third place in February and maintained that position in March, showing an upward trend from its fifth-place ranking in December 2025. The CBD/THC 2:1 Relief Tincture (600mg CBD, 300mg THC, 30ml) fell slightly from third to fourth place since December, while the CBG/THC 4:1 Focus Tincture (600mg CBG, 150mg THC, 30ml, 1oz) remained in the fifth position for the last two months. Overall, the rankings indicate stable performance for the top two tinctures, with notable growth for the Hybrid RSO Dablicator.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
